Compile Data Set for Download or QSAR
Report error Found 4 Enz. Inhib. hit(s) with all data for entry = 9589
TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM10958((3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyr...)
Affinity DataEC50:  25nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM476174((−)-N1-norphenylcarbamoyleseroline | US10864...)
Affinity DataEC50:  62nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM476178((−)-N8-norphenylcarbamoyleseroline | US10864...)
Affinity DataEC50:  62nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetAcetylcholinesterase(Human)
Aristea Translational Medicine

US Patent
LigandPNGBDBM476179((−)-N1, N8-bisnorphenylcarbamoyleseroline | ...)
Affinity DataEC50:  100nMAssay Description:To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent